Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) Peptide
-
- Target See all KCTD17 products
- KCTD17 (Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YGSEDQAEFL CVVSKELHST PNGLSSESSR KTKSTEEQLE EQQQQEEEVE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KCTD17 antibody,
Alternative Names: KCTD17 control peptide, KCTD17 antibody Blocking Peptide, Anti-KCTD17 Blocking Peptide, Potassium Channel Tetramerisation Domain Containing 17 Blocking Peptide, FLJ12242 Blocking Peptide, KCTD17, KCTD-17, KCTD 17, KCTD-17 Blocking Peptide, KCTD 17 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- KCTD17 (Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))
- Background
- KCTD17 may be involved in identical protein binding and voltage-gated potassium channel activity.
- Molecular Weight
- 32 kDa
-